Show simple item record

dc.contributor.authorZaleskis, Gintaras
dc.contributor.authorGarberytė, Sima
dc.contributor.authorPavliukevičienė, Božena
dc.contributor.authorKrasko, Jan Aleksander
dc.contributor.authorSkapas, Martynas
dc.contributor.authorTalaikis, Martynas
dc.contributor.authorDarinskas, Adas
dc.contributor.authorŽibutytė, Lavija
dc.contributor.authorPašukonienė, Vita
dc.date.accessioned2023-09-18T20:44:02Z
dc.date.available2023-09-18T20:44:02Z
dc.date.issued2021
dc.identifier.issn0250-7005
dc.identifier.other(PMID)33952461
dc.identifier.urihttps://etalpykla.vilniustech.lt/handle/123456789/152164
dc.description.abstractBackground/Aim: Liposomal Doxorubicin (lipDOX) and free Doxorubicin (DOX) are reported to exhibit similar antitumor efficacy. However, cellular internalization mechanisms of lipDOX are still a subject of controversy. Materials and Methods: Intact and permeabilized cells were exposed for short time to lipDOX and free DOX and drug intracellular content was evaluated by flow cytometry. Then, the antiproliferative capacities of lipDOX and free DOX were compared by the leukocyte nadir test in mice in vivo. Results: The fluorescence increase was 11.2-fold higher in intact cells and 19.7-fold higher in permeabilized cells after exposure to free DOX as compared to lipDOX. Mice injected with DOX showed pronounced antiproliferative activity with a leukocyte count decrease to 2.8±0.65 k/μl (p<0.01) – an effect significantly stronger than that in the lipDOX group. Conclusion: Intact and permeabilized cells internalize free DOX manifold faster than lipDOX. The LipDOX formulation does not induce a remarkable leukocyte nadir effect in vivo.eng
dc.formatPDF
dc.format.extentp. 2363-2370
dc.format.mediumtekstas / txt
dc.language.isoeng
dc.relation.isreferencedbyScience Citation Index Expanded (Web of Science)
dc.relation.isreferencedbyScopus
dc.source.urihttps://doi.org/10.21873/anticanres.15011
dc.titleComparative evaluation of cellular uptake of free and liposomal doxorubicin following short term exposure
dc.typeStraipsnis Web of Science DB / Article in Web of Science DB
dcterms.references37
dc.type.pubtypeS1 - Straipsnis Web of Science DB / Web of Science DB article
dc.contributor.institutionNacionalinis vėžio institutas
dc.contributor.institutionValstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras
dc.contributor.institutionVilniaus universitetas
dc.contributor.institutionValstybinis mokslinių tyrimų institutas Fizinių ir technologijos mokslų centras
dc.contributor.institutionNacionalinis vėžio institutas Vilniaus Gedimino technikos universitetas
dc.contributor.facultyFundamentinių mokslų fakultetas / Faculty of Fundamental Sciences
dc.subject.researchfieldN 010 - Biologija / Biology
dc.subject.researchfieldM 001 - Medicina / Medicine
dc.subject.researchfieldN 004 - Biochemija / Biochemistry
dc.subject.researchfieldN 003 - Chemija / Chemistry
dc.subject.researchfieldN 002 - Fizika / Physics
dc.subject.vgtuprioritizedfieldsFM0202 - Ląstelių ir jų biologiškai aktyvių komponentų tyrimai / Investigations on cells and their biologically active components
dc.subject.ltspecializationsL105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies
dc.subject.enliposomal doxorubicin
dc.subject.enapoptotic cell
dc.subject.endrug leakage
dc.subject.endrug uptake
dc.subject.enpegylated liposomes
dcterms.sourcetitleAnticancer research
dc.description.issueiss. 5
dc.description.volumevol. 41
dc.publisher.nameInternational Institute of Anticancer Research
dc.publisher.cityAttiki, Greece
dc.identifier.doi33952461
dc.identifier.doi000648665800003
dc.identifier.doi10.21873/anticanres.15011
dc.identifier.elaba94551826


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record